Atlas Venture Life Science Advisors, LLC
Atlas Venture Life Science Advisors, LLC reported 7 holdings worth US$881M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 13, 2026
Atlas Venture Life Science Advisors, LLC reported 7 holdings worth US$881M as of Jun 30, 2026. Largest: Kymera Therapeutics, Inc., Dyne Therapeutics, Inc. and Sionna Therapeutics, Inc. Filed Aug 13, 2026 (Form 13F).
- Holdings
- 7
- Value as reported
- US$881M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Kymera Therapeutics, Inc. | 2.85M | US$327M | 37.1% |
| Dyne Therapeutics, Inc. | 6.8M | US$151M | 17.1% |
| Sionna Therapeutics, Inc. | 3M | US$132M | 15.0% |
| Kailera Therapeutics, Inc. | 5.17M | US$114M | 12.9% |
| Disc Medicine, Inc. | 1.51M | US$111M | 12.6% |
| Q32 Bio Inc. | 2.72M | US$34.6M | 3.9% |
| Korro Bio, Inc. | 963K | US$12.7M | 1.4% |